Details for New Drug Application (NDA): 211856
✉ Email this page to a colleague
The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 211856
Tradename: | CHOLESTYRAMINE |
Applicant: | Alkem Labs Ltd |
Ingredient: | cholestyramine |
Patents: | 0 |
Pharmacology for NDA: 211856
Mechanism of Action | Bile-acid Binding Activity |
Suppliers and Packaging for NDA: 211856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 211856 | ANDA | Bryant Ranch Prepack | 63629-9196 | 63629-9196-1 | 368.76 g in 1 JAR (63629-9196-1) |
CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 211856 | ANDA | Ascend Laboratories, LLC | 67877-298 | 67877-298-37 | 368.76 g in 1 JAR (67877-298-37) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/PACKET | ||||
Approval Date: | Oct 19, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/SCOOPFUL | ||||
Approval Date: | Oct 19, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription